Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

282 trials

NCT06271057
Recruiting
Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
Phase 2 · France · 13 sites
Registry update: 4 Jun 2026
NCT06249191
Recruiting
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
Phase 1/2 · United States · 1 site
Registry update: 7 Jul 2026
NCT06224309
Recruiting
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Not applicable · Canada · 1 site
Registry update: 1 Oct 2026
NCT06594640
Recruiting
R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Phase 1/2 · China · 1 site
Registry update: 10 Jun 2026
NCT06569485
Recruiting
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients
Phase 2 · China · 1 site
Registry update: 26 Aug 2024
NCT06451497
Recruiting
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Phase 1 · United States · 3 sites
Registry update: 2 Apr 2026
NCT06352242
Recruiting
Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma?
Not applicable · France · 2 sites
Registry update: 22 Jun 2026
NCT06015880
Recruiting
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 1 · United States · 8 sites
Registry update: 26 Oct 2026
NCT06116110
Recruiting
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Not applicable · United States · 11 sites
Registry update: 5 Aug 2026
NCT06521255
Recruiting
Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 3 · China · 20 sites
Registry update: 25 Jul 2024
NCT06002659
Recruiting
CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study)
Phase 1/2 · Sweden · 2 sites
Registry update: 10 Nov 2026
2022-501554-11-00
Recruiting
FILOCLL015 - GLORIFY - A phase 2 study evaluating the bispecific CD3xCD20 antibody GLOfitamab in combination with rituximab or obinutuzumab plus cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) in patients with RIchter syndrome as Frontline therapY
Phase 2 · France · 27 sites
Registry update: 20 Aug 2026
NCT06375733
Recruiting
A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
Phase 1/2 · China · 2 sites
Registry update: 12 Aug 2025
NCT06191887
Recruiting
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
Phase 1 · United States · 1 site
Registry update: 13 Feb 2026
NCT05887167
Recruiting
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Phase 1 · United States · 1 site
Registry update: 10 Aug 2026
NCT05934084
Recruiting
Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors
Not applicable · Italy · 40 sites
Registry update: 11 Sept 2026
NCT06227026
Recruiting
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
Phase 1 · United States · 1 site
Registry update: 26 Aug 2026
NCT05836896
Recruiting
A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies
Phase 1 · Germany · 1 site
Registry update: 27 Aug 2026
NCT06774326
Recruiting
Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines
Not applicable · Italy · 1 site
Registry update: 14 Jan 2025
NCT06238648
Recruiting
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
Phase 2 · United States · 6 sites
Registry update: 26 Sept 2024

Ordered by registry start date. Freshness and sponsorship never change the order.